Summary
Jiabin Xu is a policy analyst in Geneva who combines an 11-year background across biomedical research, pharma translational medicine, and global health policy to translate complex science into actionable advocacy and funding insights. With a PhD in Biomedical Sciences focused on drug repurposing and Wnt-targeted oncology, plus hands-on experience managing preclinical safety and IND submissions in industry, she bridges laboratory rigor and regulatory realities. At the JLI Centre for Global Health Diplomacy she analyzes health financing trends, drafts policy briefs, and cultivates stakeholder engagement—including outreach to Chinese partners informed by prior regulatory intelligence work on AI in health. Unusually for a policy analyst, she has both a winning track record in translational innovation competitions and direct WHO guideline experience, giving her a practical edge in shaping policy that can be implemented.
10 years of coding experience
7 years of employment as a software developer
International Baccalaureate Bilingual Diploma, International Baccalaureate Bilingual Diploma at International School of Geneva
Master of Science (MSc), Medical Biology, specialised in Pharmacology, Master of Science (MSc), Medical Biology, specialised in Pharmacology at Université de Lausanne
Doctor (PhD) of Science, Biomedical Science, Doctor (PhD) of Science, Biomedical Science at University of Geneva
Bachelor of Science (BSc Hons), Medical Science, Bachelor of Science (BSc Hons), Medical Science at University of Leeds
French, Chinese, English